b2473e0f9836cb80e2b3597a63717dde  288423.pdf
c3e1859f592639abbc02b8eb5fe89db72b5b166b  288423.pdf
38c9b5923696e887f0a2d245346df255983a620ed74f74456136cb59dfe686d7  288423.pdf

Title:          Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial
Subject:        Leukemia 31, 2435 (2017). doi:10.1038/leu.2017.111
Author:         N J Bahlis
Creator:        Arbortext Advanced Print Publisher 10.0.1465/W Unicode
Producer:       Acrobat Distiller 10.1.8 (Windows)
CreationDate:   Sat Sep 30 12:22:36 2017 CEST
ModDate:        Thu Oct 12 19:39:51 2017 CEST
Tagged:         no
UserProperties: no
Suspects:       no
Form:           AcroForm
JavaScript:     no
Pages:          8
Encrypted:      no
Page size:      595.276 x 790.866 pts
Page rot:       0
File size:      2100224 bytes
Optimized:      yes
PDF version:    1.6


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
DFMEFK+AdvEls-ent4                   Type 1C           WinAnsi          yes yes no     220  0
DFMDPC+Arial-BoldMT                  Type 1C           WinAnsi          yes yes no     187  0
DFMEBC+AdvTT5afe5d37.B               Type 1C           WinAnsi          yes yes no     188  0
DFMEBD+AdvOTa20b42a7                 Type 1C           WinAnsi          yes yes no     195  0
DFMEBE+AdvOTa20b42a7+fb              Type 1C           Custom           yes yes yes    196  0
DFMEBF+AdvTT6780a46b                 Type 1C           WinAnsi          yes yes no     197  0
DFMEDF+AdvOT46dcae81                 Type 1C           WinAnsi          yes yes no     198  0
DFMEDG+AdvOT46dcae81+fb              Type 1C           Custom           yes yes yes    202  0
DFMEDH+AdvOT65f8a23b.I               Type 1C           WinAnsi          yes yes no     203  0
DFMEDI+AdvOT8608a8d1+2a              Type 1C           Custom           yes yes yes    204  0
DFMEEJ+AdvOT3b30f6db.B               Type 1C           WinAnsi          yes yes no     215  0
DFMEEK+AdvTT2876772e+20              Type 1C           WinAnsi          yes yes no     216  0
DFMEJK+AdvPi1                        Type 1C           WinAnsi          yes yes no      54  0
DFMEKK+AdvOT919a0533.B               Type 1C           WinAnsi          yes yes no      51  0
DFMEKL+AdvTT6780a46b+20              Type 1C           WinAnsi          yes yes no      52  0
DFMELM+AdvOT7d2ebc01                 Type 1C           WinAnsi          yes yes no      59  0
DGIIDM+AdvTT6780a46b+fb              Type 1C           Custom           yes yes yes     62  0


Jhove (Rel. 1.28.0, 2023-05-18)
 Date: 2024-02-06 02:40:20 CET
 RepresentationInformation: 288423.pdf
  ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16)
  LastModified: 2024-02-05 13:31:44 CET
  Size: 2100224
  Format: PDF
  Version: 1.6
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 245
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    PageLayout: SinglePage
    PageMode: UseNone
    Outlines: 
     Item: 
      Title: Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST’trial
      Destination: title_link
      Children: 
       Item: 
        Title: Introduction
        Destination: A1
       Item: 
        Title: Subjects and methods
        Destination: A2
        Children: 
         Item: 
          Title: Study design
          Destination: B1
         Item: 
          Title: Patients
          Destination: B2
         Item: 
          Title: Assessments
          Destination: B3
       Item: 
        Title: Table 1 Baseline patient characteristics by response subgroups
        Destination: tab_bktblt1
        Children: 
         Item: 
          Title: Statistical analysis
          Destination: B4
       Item: 
        Title: Results
        Destination: A3
        Children: 
         Item: 
          Title: Patients
          Destination: B5
         Item: 
          Title: Responses, time to response and duration of response
          Destination: B6
       Item: 
        Title: Figure 1 Cumulative response by treatment month for patients who achieved VGPR or better as best response.
        Destination: fig_bkfigf1
        Children: 
         Item: 
          Title: Progression-free survival
          Destination: B7
         Item: 
          Title: Overall survival
          Destination: B8
         Item: 
          Title: Time to second-line antimyeloma therapy
          Destination: B9
       Item: 
        Title: Figure 2 Kaplan–Meier estimates of duration of response.
        Destination: fig_bkfigf2
        Children: 
         Item: 
          Title: Safety
          Destination: B10
       Item: 
        Title: Discussion
        Destination: A4
       Item: 
        Title: Figure 3 Kaplan–Meier estimates of PFS.
        Destination: fig_bkfigf3
       Item: 
        Title: Figure 4 Kaplan–Meier estimates of OS.
        Destination: fig_bkfigf4
       Item: 
        Title: Table 2 Time to second-line antimyeloma treatment by response subgroups
        Destination: tab_bktblt2
       Item: 
        Title: Figure 2 Kaplan–Meier estimates of duration of response.
        Destination: A5
       Item: 
        Title: Table 3 Grade 3„/„4 TEAEs of interest by response groups
        Destination: tab_bktblt3
       Item: 
        Title: Figure 2 Kaplan–Meier estimates of duration of response.
        Destination: A6
       Item: 
        Title: ACKNOWLEDGEMENTS
        Destination: M1
       Item: 
        Title: REFERENCES
        Destination: M4
   Info: 
    Title: Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial
    Author: N J Bahlis
    Subject: Leukemia 31, 2435 (2017). doi:10.1038/leu.2017.111
    Creator: Arbortext Advanced Print Publisher 10.0.1465/W Unicode
    Producer: Acrobat Distiller 10.1.8 (Windows)
    CreationDate: Sat Sep 30 12:22:36 CEST 2017
    ModDate: Thu Oct 12 20:09:51 CEST 2017
   ID: 0xe8e084a9d7fb54fc34b22fc4195a1ef6, 0xfc40448bf0f0bd40b28362186297b7a9
   Filters: 
    FilterPipeline: FlateDecode
    FilterPipeline: DCTDecode
   Images: 
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 3043
      ImageHeight: 2474
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 1757
      ImageHeight: 5300
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 3709
      ImageHeight: 3781
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 3848
      ImageHeight: 3767
      BitsPerSample: 8
      BitsPerSampleUnit: integer
   Fonts: 
    Type1: 
     Font: 
      BaseFont: DFMEBD+AdvOTa20b42a7
      FontSubset: true
      FirstChar: 66
      LastChar: 122
      FontDescriptor: 
       FontName: DFMEBD+AdvOTa20b42a7
       Flags: Serif, Nonsymbolic
       FontBBox: -72, -239, 979, 906
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMEBE+AdvOTa20b42a7+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: DFMEBE+AdvOTa20b42a7+fb
       Flags: Symbolic
       FontBBox: 0, 0, 531, 708
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: DFMEBF+AdvTT6780a46b
      FontSubset: true
      FirstChar: 37
      LastChar: 122
      FontDescriptor: 
       FontName: DFMEBF+AdvTT6780a46b
       Flags: Nonsymbolic
       FontBBox: -41, -250, 875, 843
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMEDF+AdvOT46dcae81
      FontSubset: true
      FirstChar: 37
      LastChar: 252
      FontDescriptor: 
       FontName: DFMEDF+AdvOT46dcae81
       Flags: Nonsymbolic
       FontBBox: -41, -250, 833, 875
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMEDG+AdvOT46dcae81+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 3
      FontDescriptor: 
       FontName: DFMEDG+AdvOT46dcae81+fb
       Flags: Symbolic
       FontBBox: 0, 0, 739, 718
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: DFMEDH+AdvOT65f8a23b.I
      FontSubset: true
      FirstChar: 37
      LastChar: 121
      FontDescriptor: 
       FontName: DFMEDH+AdvOT65f8a23b.I
       Flags: Nonsymbolic
       FontBBox: -104, -250, 885, 864
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMEDI+AdvOT8608a8d1+2a
      FontSubset: true
      FirstChar: 1
      LastChar: 3
      FontDescriptor: 
       FontName: DFMEDI+AdvOT8608a8d1+2a
       Flags: Symbolic
       FontBBox: 0, -437, 1385, 937
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: DFMEKK+AdvOT919a0533.B
      FontSubset: true
      FirstChar: 46
      LastChar: 117
      FontDescriptor: 
       FontName: DFMEKK+AdvOT919a0533.B
       Flags: Nonsymbolic
       FontBBox: -31, -250, 656, 875
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMEKL+AdvTT6780a46b+20
      FontSubset: true
      FirstChar: 150
      LastChar: 150
      FontDescriptor: 
       FontName: DFMEKL+AdvTT6780a46b+20
       Flags: Nonsymbolic
       FontBBox: 0, -114, 1156, 750
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMEJK+AdvPi1
      FontSubset: true
      FirstChar: 52
      LastChar: 52
      FontDescriptor: 
       FontName: DFMEJK+AdvPi1
       Flags: Nonsymbolic
       FontBBox: 13, -323, 958, 824
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMEEJ+AdvOT3b30f6db.B
      FontSubset: true
      FirstChar: 44
      LastChar: 119
      FontDescriptor: 
       FontName: DFMEEJ+AdvOT3b30f6db.B
       Flags: Nonsymbolic
       FontBBox: -31, -250, 875, 895
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMEEK+AdvTT2876772e+20
      FontSubset: true
      FirstChar: 146
      LastChar: 151
      FontDescriptor: 
       FontName: DFMEEK+AdvTT2876772e+20
       Flags: Nonsymbolic
       FontBBox: -218, -197, 1302, 781
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMDPC+Arial-BoldMT
      FontSubset: true
      FirstChar: 69
      LastChar: 80
      FontDescriptor: 
       FontName: DFMDPC+Arial-BoldMT
       Flags: Nonsymbolic
       FontBBox: -628, -376, 2000, 1010
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMELM+AdvOT7d2ebc01
      FontSubset: true
      FirstChar: 48
      LastChar: 57
      FontDescriptor: 
       FontName: DFMELM+AdvOT7d2ebc01
       Flags: Nonsymbolic
       FontBBox: -31, -208, 958, 916
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMEFK+AdvEls-ent4
      FontSubset: true
      FirstChar: 111
      LastChar: 111
      FontDescriptor: 
       FontName: DFMEFK+AdvEls-ent4
       Flags: Nonsymbolic
       FontBBox: 0, -343, 1166, 1218
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DFMEBC+AdvTT5afe5d37.B
      FontSubset: true
      FirstChar: 65
      LastChar: 100
      FontDescriptor: 
       FontName: DFMEBC+AdvTT5afe5d37.B
       Flags: Nonsymbolic
       FontBBox: -31, -250, 895, 864
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: DGIIDM+AdvTT6780a46b+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: DGIIDM+AdvTT6780a46b+fb
       Flags: Symbolic
       FontBBox: 9, 0, 875, 750
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 4.0-c316 44.253921, Sun Oct 01 2006 17:14:39">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about="doi:10.1038/leu.2017.111"
            xmlns:dc="http://purl.org/dc/elements/1.1/">
         <dc:format>application/pdf</dc:format>
         <dc:identifier>&#xA;            doi:10.1038/leu.2017.111</dc:identifier>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>N J Bahlis</rdf:li>
               <rdf:li>A Corso</rdf:li>
               <rdf:li>L-O Mugge</rdf:li>
               <rdf:li>Z-X Shen</rdf:li>
               <rdf:li>P Desjardins</rdf:li>
               <rdf:li>A-M Stoppa</rdf:li>
               <rdf:li>O Decaux</rdf:li>
               <rdf:li>T de Revel</rdf:li>
               <rdf:li>M Granell</rdf:li>
               <rdf:li>G Marit</rdf:li>
               <rdf:li>H Nahi</rdf:li>
               <rdf:li>H Demuynck</rdf:li>
               <rdf:li>S-Y Huang</rdf:li>
               <rdf:li>S Basu</rdf:li>
               <rdf:li>T H Guthrie</rdf:li>
               <rdf:li>A Ervin-Haynes</rdf:li>
               <rdf:li>J Marek</rdf:li>
               <rdf:li>G Chen</rdf:li>
               <rdf:li>T Facon</rdf:li>
               <rdf:li> </rdf:li>
            </rdf:Seq>
         </dc:creator>
         <dc:description>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Leukemia 31, 2435 (2017). doi:10.1038/leu.2017.111</rdf:li>
            </rdf:Alt>
         </dc:description>
         <dc:publisher>
            <rdf:Bag>
               <rdf:li>Nature Publishing Group</rdf:li>
            </rdf:Bag>
         </dc:publisher>
         <dc:rights>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">© 2017 The Author(s)</rdf:li>
            </rdf:Alt>
         </dc:rights>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial</rdf:li>
            </rdf:Alt>
         </dc:title>
      </rdf:Description>
      <rdf:Description rdf:about="doi:10.1038/leu.2017.111"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/">
         <pdf:Producer>Acrobat Distiller 10.1.8 (Windows)</pdf:Producer>
      </rdf:Description>
      <rdf:Description rdf:about="doi:10.1038/leu.2017.111"
            xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">
         <prism:copyright>&#xA;            ©  </prism:copyright>
         <prism:doi>10.1038/leu.2017.111</prism:doi>
         <prism:eIssn>1476-5551</prism:eIssn>
         <prism:endingPage>2442</prism:endingPage>
         <prism:issn>0887-6924</prism:issn>
         <prism:number>11</prism:number>
         <prism:publicationName/>
         <prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
         <prism:startingPage>2435</prism:startingPage>
         <prism:volume>31</prism:volume>
         <prism:publicationDate>
            <rdf:Bag>
               <rdf:li>2017 2017-04 04-04 28</rdf:li>
            </rdf:Bag>
         </prism:publicationDate>
         <prism:url>
            <rdf:Bag>
               <rdf:li>&#xA;                http://dx.doi.org/10.1038/leu.2017.111</rdf:li>
            </rdf:Bag>
         </prism:url>
      </rdf:Description>
      <rdf:Description rdf:about="doi:10.1038/leu.2017.111"
            xmlns:xap="http://ns.adobe.com/xap/1.0/">
         <xap:CreateDate>2017-09-30T10:22:36Z</xap:CreateDate>
         <xap:CreatorTool>Arbortext Advanced Print Publisher 10.0.1465/W Unicode</xap:CreatorTool>
         <xap:Label>Leukemia 31, 2435 (2017 2017). doi:10.1038/leu.2017.111</xap:Label>
         <xap:MetadataDate>2017-10-12T23:09:51+05:30</xap:MetadataDate>
         <xap:ModifyDate>2017-10-12T23:09:51+05:30</xap:ModifyDate>
         <xap:Identifier>
            <rdf:Bag>
               <rdf:li>&#xA;                doi:10.1038/leu.2017.111</rdf:li>
            </rdf:Bag>
         </xap:Identifier>
      </rdf:Description>
      <rdf:Description rdf:about="doi:10.1038/leu.2017.111"
            xmlns:xapRights="http://ns.adobe.com/xap/1.0/rights/">
         <xapRights:Marked>True</xapRights:Marked>
      </rdf:Description>
      <rdf:Description rdf:about="doi:10.1038/leu.2017.111"
            xmlns:xapMM="http://ns.adobe.com/xap/1.0/mm/">
         <xapMM:DocumentID>uuid:2eceeca2-4fd1-49c0-aee7-20af60ebdc58</xapMM:DocumentID>
         <xapMM:InstanceID>uuid:4b3af67c-0180-4f5e-bb1e-c97adf9c0289</xapMM:InstanceID>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 186, 423, 265, 432
      Annotation: 
       Subtype: Link
       Rect: 65, 353, 69, 362
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 70, 353, 74, 362
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 184, 333, 187, 341
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 188, 333, 192, 341
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 258, 291, 262, 300
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 263, 261, 273, 270
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 59, 240, 62, 249
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 63, 240, 70, 249
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 277, 199, 283, 208
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 454, 375, 461, 384
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 513, 323, 520, 332
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 521, 323, 528, 332
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 347, 262, 354, 271
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 543, 231, 549, 240
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 57, 65, 115, 72
      Annotation: 
       Subtype: Link
       Rect: 278, 734, 351, 742
     Thumb: true
    Page: 
     Label: 2
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 173, 676, 179, 684
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 239, 423, 245, 431
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 390, 540, 396, 548
       Destination: 41
     Thumb: true
    Page: 
     Label: 3
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 59, 390, 87, 399
       Destination: 1
      Annotation: 
       Subtype: Link
       Rect: 517, 705, 524, 714
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 402, 551, 438, 560
       Destination: 7
      Annotation: 
       Subtype: Link
       Rect: 430, 530, 466, 539
       Destination: 7
      Annotation: 
       Subtype: Link
       Rect: 505, 500, 536, 509
       Destination: 16
     Thumb: true
    Page: 
     Label: 4
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 522, 691, 555, 700
       Destination: 24
      Annotation: 
       Subtype: Link
       Rect: 313, 403, 346, 412
       Destination: 29
      Annotation: 
       Subtype: Link
       Rect: 465, 373, 496, 382
       Destination: 29
      Annotation: 
       Subtype: Link
       Rect: 400, 167, 432, 175
       Destination: 29
     Thumb: true
    Page: 
     Label: 5
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 177, 209, 205, 218
       Destination: 36
     Thumb: true
    Page: 
     Label: 6
     Thumb: true
    Page: 
     Label: 7
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 144, 279, 161, 288
       Destination: 41
      Annotation: 
       Subtype: Link
       Rect: 111, 89, 118, 98
       Destination: 41
     Thumb: true
    Page: 
     Label: 8
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 450, 347, 559, 354
      Annotation: 
       Subtype: Link
       Rect: 311, 338, 331, 345
     Thumb: true
  Checksum: 02f78e3c
   Type: CRC32
  Checksum: b2473e0f9836cb80e2b3597a63717dde
   Type: MD5
  Checksum: c3e1859f592639abbc02b8eb5fe89db72b5b166b
   Type: SHA-1
  Checksum: 38c9b5923696e887f0a2d245346df255983a620ed74f74456136cb59dfe686d7
   Type: SHA-256